membrane. Rem-inhibited Ca V 1.2 channels were supramodulated by BAY K 8644 (10-fold increase) compared to control channels (3-fold increase). However, Rem prevented protein kinase A-mediated upregulation of I Ca,L , an effect achieved without disrupting the sympathetic signaling cascade because protein kinase A modulation of I KS (slow component of the delayed rectifier potassium current) remained intact. In accord with its functional impact on I Ca,L , Rem selectively prevented protein kinase A-but not BAY K 8644 -induced prolongation of the cardiac action potential duration. A GTP-binding-deficient Rem[T94N] mutant was functionally inert with respect to I Ca,L inhibition. A chimeric construct, Rem 265 -H, featuring a swap of the Rem C-terminal tail for the analogous domain from H-Ras, inhibited I Ca,L and Q max to the same extent as wild-type Rem, despite lacking the capacity to autonomously localize to the sarcolemma.
by associating with auxiliary Ca V ␤ subunits. 12, 13 Distinct RGK GTPases (Rad/Rem/Rem2/Gem/Kir subfamily of Raslike GTPases) are expressed in heart, and changes in their levels occur under different pathological conditions. For example, expression of Rem in ventricular myocytes is downregulated during conditions mimicking inflammation 8 ; Gem is upregulated in the failing human heart 14 ; and Rad knockout mice develop cardiac hypertrophy. 15 Owing to their strong impact on Ca V 1.2 channels, RGK GTPases may profoundly regulate Ca 2ϩ signaling in heart under both physiological and disease states.
This study focuses on 2 fundamental questions: (1) How do RGK GTPases inhibit whole-cell I Ca,L in heart? (2) Can RGK GTPase-inhibited channels be functionally rescued by pharmacological or physiological molecules? Overexpressing Gem or Rad in heart dramatically inhibits I Ca,L . 16, 17 It has been suggested that RGK proteins inhibit I Ca,L in heart by interfering with channel trafficking, thereby reducing the surface density of cardiac Ca V 1.2 channels. However, in other cell types, it has been demonstrated that RGK proteins can inhibit I Ca without reducing the surface density of channels. 18, 19 In HEK 293 cells, Rem inhibits recombinant Ca V 1.2 channels using 3 separate mechanisms: by reducing surface density of channels, accomplished through enhancing dynamin-dependent endocytosis; by immobilizing Ca V channel voltage sensors; and by arresting channels that remain on the surface in a low open probability (P o ) gating mode. 20 Whether RGK GTPases use a similar multiplicity of mechanisms to inhibit Ca V 1.2 channels in heart has not been explored. Ambiguity also surrounds the role played by key structural features of RGK GTPases in blocking I Ca,L in heart. For example, GTP binding to the NBD is dispensable for Rem inhibition of Ca V 1 and 2 channels reconstituted in HEK 293 cells. 20 However, in heart, a GTP-binding-deficient Rad mutant displays a dominant negative effect that results in enhancement of I Ca,L . 17 It is unknown whether these variations reflect genuine differences among distinct RGK GT-Pases, or whether they are cell type-specific. Similarly, in some systems, membrane targeting of the NBD is necessary and sufficient for Rem inhibition of I Ca,L . 18, 21, 22 Whether this rule holds true in heart is unclear. Finally, it is unknown whether RGK GTPase-inhibited Ca V 1.2 channels are irretrievably lost or whether they can be acutely rescued by agents that normally upregulate I Ca,L in heart. Discovering molecules that can functionally rescue RGK GTPaseinhibited Ca V 1.2 channels may not only refine understanding of the mechanisms underlying this modulation but also have potential therapeutic applications by reversing cardiac dysfunction arising from RGK GTPase-mediated block of cardiac I Ca,L .
Here, we find that overexpressing Rem in isolated guinea pig ventricular myocytes markedly inhibits I Ca,L (90% reduction) and more modestly decreases maximum gating charge (Q max ) (33% reduction), without appreciably decreasing the surface density of channels. Contrary to results in reconstituted systems, GTP binding to the NBD was necessary for Rem inhibition of I Ca,L in heart. However, membrane targeting of the NBD was neither necessary nor sufficient for blocking cardiac Ca V 1.2 channels. Rem-inhibited Ca V 1.2 channels could be selectively upregulated by BAY K 8644 but were insensitive to the physiological sympathetic ␤-adrenergic signaling pathway. The results offer a new perspective on the mechanisms of RGK GTPase inhibition of cardiac I Ca,L and reveal an intriguing crosstalk between 2 opposing signaling pathways that converge on Ca V 1.2 channels in the heart.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Construction of Adenoviral Vectors
Adenoviral vectors were generated using the AdEasy XL system (Stratagene, La Jolla, Calif) according to the instructions of the manufacturer. Adenoviral amplification and purification were as described previously. 23, 24 
Cell Culture and Transfection
Primary cultures of adult guinea pig heart cells were prepared as described previously. 25 Adult male Hartley guinea pigs were killed with an overdose of isoflurane in accordance with the guidelines of the Columbia University Animal Care and Use Committee. Hearts were excised, and ventricular myocytes were isolated by enzymatic digestion using a Langendorff perfusion apparatus and cultured on laminin-coated coverslips. Myocytes were infected with adenovirus 3 to 5 hours after initial plating.
Immunofluorescence Detection of Ca V 1.2 Channels

Isolated heart cells plated on glass-bottom 35-mm
MatTek dishes were infected with adenovirus. After 24 hours, cells were fixed with 2% paraformaldehyde in PBS and washed with 0.1 mol/L glycine-PBS. Fixed myocytes were permeabilized with 0.2% Triton X-100 in PBS followed by a 1 hour of incubation in blocking solution (3% goat serum/1% BSA/0.1% Triton X-100). Cells were then incubated with anti-Ca v 1.2 antibody (1:1000 rabbit polyclonal) in blocking media for 1 hour at room temperature. Cells were then washed and exposed to Alexa Fluor 594 -conjugated goat anti-rabbit IgG (HϩL) (1:400, Invitrogen Molecular Probes, Carlsbad, Calif) for 1 hour at room temperature in blocking solution. Immunofluorescence detection was performed using a Leica TCS SP2 AOBS MP confocal microscope system (Leica Microsystems, Heidelberg, Germany). 
Non-standard Abbreviations and Acronyms
Electrophysiology
Whole-cell and gating currents were recorded from cultured ventricular myocytes as described previously. 23
Statistics
Pooled data are presented as meansϮSEM, and probability values were calculated using Student's 2-tailed t test; PϽ0.05 was considered significant.
Results
Rem Inhibition of Ca V 1.2 Channels in Adult Guinea Pig Heart Cells
We assessed the impact of Rem on endogenous Ca V 1.2 channels in cultured adult guinea pig ventricular myocytes using adenovirus-mediated somatic gene transfer. Control, uninfected myocytes displayed robust whole-cell Ca V 1.2 currents that activated at a threshold of Ϫ40 mV and peaked at 0 mV ( Figure 1A Table I ). At the 0-mV voltage step, peak current density (I peak ) was reduced by Ϸ90% compared to control uninfected cells (I peak ϭ2.67Ϯ0.35 pA/pF, nϭ7, for CFP-Rem-expressing cells; I peak ϭ18.82Ϯ2.31 pA/pF, nϭ7, for control cells; Pϭ0.0007; Online Table I ). It has been established that RGK GTPases target the plasma membrane using electrostatic and hydrophobic interactions involving amino acid residues in the distal C terminus. 26 In HEK 293 cells, deleting the distal Rem C-terminal extension (generating Rem 265 ; Figure 1G , top) eliminates Rem targeting to the plasma membrane and prevents its capacity to block I Ca . 13, 22 Similarly, adult guinea pig myocytes infected with yellow fluorescent protein (YFP)-Rem 265 adenovirus displayed YFP fluorescence throughout the cytosol and nuclei, without any evident targeting to the sarcolemma or T-tubule network ( Figure 1G , bottom; Online Figure I ). Most importantly, myocytes expressing YFP-Rem 265 exhibited robust wholecell Ca V 1.2 currents that were essentially the same as those recorded from uninfected cells with respect to amplitude and voltage-dependent properties ( Figure 1H and 1I; I peak at 0 mVϭ21.69Ϯ1.93 pA/pF, nϭ6; Pϭ0.36 compared to uninfected myocytes; Online Table I ). Because of its inertness in blocking I Ca,L , we used cells expressing YFP-Rem 265 as effective controls in subsequent experiments. These results establish that overexpressing Rem in guinea pig ventricular myocytes dramatically decreases I Ca,L , in agreement with previous observations made using Gem and Rad. 16, 17 The marked inhibition of I Ca,L suggests that in this experimental paradigm, most Ca V 1.2 channels are modified by Rem. This fact greatly simplifies and justifies the use of this experimental system to probe the 
Impact of Rem on Q max and Surface Density of Ca V 1.2 Channels in Heart
In HEK 293 cells, Rem inhibits recombinant Ca V 1.2 channels by 3 distinct mechanisms. 20 It has been suggested that Gem and Rad inhibit cardiac I Ca,L by disrupting channel trafficking and, thus, reducing Ca V 1.2 channel surface density. 16, 17 However, whether RGK GTPases use multiple mechanisms to inhibit Ca V 1.2 channels in heart has not been rigorously studied. To address this deficit, we next investigated the impact of Rem on gating charge and subcellular localization of Ca V 1.2 channels in heart cells ( Figure 2 ).
To isolate Ca V 1.2 channel gating currents, we used a holding potential of Ϫ50 mV and blocked ionic currents with 2 mmol/L CdCl 2 /0.1 mmol/L LaCl 3 . 23 Comparing exemplar ON gating currents between Rem 265 -and Rem-expressing myocytes indicated that Rem reduced, but did not eliminate this gating parameter (Figure 2A ). This impression was confirmed in population gating charge versus voltage data: myocytes expressing Rem displayed a 33% reduction in maximal gating charge (Q max ) compared to control cells expressing Rem 265 ( Figure 2B ; Q max ϭ8.47Ϯ0.56 fC/pF, nϭ8 for Rem 265 ; Q max ϭ5.78Ϯ0.41 fC/pF, nϭ7, for Remexpressing myocytes, Pϭ0.002).
We used immunofluorescence to examine the impact of Rem on Ca V 1.2 channel subcellular localization in heart cells ( Figure 2C ). In myocytes expressing YFP-Rem 265 , Ca V 1.2 channel staining presented as punctate clusters organized along z-lines ( Figure 2C , top row). Cells expressing CFP-Rem displayed a Ca V 1.2 channel staining pattern similar to control cells ( Figure 2C , bottom row). The preferential targeting of CFP-Rem to the sarcolemma and T-tubules made it possible to explicitly confirm that Ca V 1.2 channel staining was present at the cell surface ( Figure 2C ). Controls in which Ca V 1.2 antibody was preincubated with immunizing antigen displayed low fluorescence, ruling out nonspecific staining (Online Figure II) . Quantifying Ca V 1.2 immunofluorescence staining across a number of cells indicated no difference between myocytes expressing Rem 265 or Rem ( Figure 2D ), in agreement with the impression gathered from visual inspection. These data argue against diminished trafficking of Ca V 1.2 channels as a dominant mechanism for Rem-induced decrease in cardiac I Ca,L .
Thus, under conditions where Rem severely depresses I Ca,L in heart, most Ca V 1.2 channels remain in the cardiac sarcolemma. In light of this, the moderate reduction in Q max suggests that Rem partially immobilizes the voltage sensors of sarcolemmal Ca V 1.2 channels. The data also suggest that Rem-modified Ca V 1.2 channels in the sarcolemma are either electrically silent or populate a low-P o gating mode. 
Selective Pharmacological Rescue of Rem-Inhibited Ca V 1.2 Channels in Heart
The notion that Rem-modified Ca V 1.2 channels remain in the sarcolemma suggested it might be possible to acutely rescue such inhibited channels pharmacologically. We investigated this possibility using the Ca V 1 channel agonist BAY K 8644. Control myocytes expressing Rem 265 showed a rapid and robust increase in current amplitude in response to 1 mol/L BAY K 8644 at all voltages ( Figure 3A through 3C). On average, control cells exhibited a 3-fold increase in currents evoked with a 0-mV test pulse ( Figure 3G ). Remarkably, cells expressing Rem also responded to 1 mol/L BAY K 8644, with a large and rapid increase in I Ca,L at all voltages ( Figure 3D through 3F). In fact, the average fold increase in I Ca,L was substantially larger for Rem-expressing myocytes compared to control cells ( Figure 3G ; fold increaseϭ3.18Ϯ0.46, nϭ6 for control YFP-Rem 265 -expressing cells; fold in-creaseϭ9.42Ϯ1.05, nϭ6 for CFP-Rem, PϽ0.005). Similar results were obtained using the Ca V channel agonist FPL-64176 (Online Figure III) . Importantly, in the presence of BAY K 8644, the whole-cell current density recorded from cells expressing Rem 265 or Rem was not significantly different ( Figure 3H ), consolidating the idea that the majority of Rem-inhibited channels remained on the surface sarcolemma. BAY K 8644 did not increase Q max in either YFP-Rem 265 -or CFP-Rem-expressing cells (Online Figure IV) , eliminating recovery of Q max as a potential mechanism to explain the larger effect of BAY K 8644 on cells expressing Rem compared to control.
The pharmacological rescue of Rem-inhibited currents was intriguing and gave reason to wonder whether physiological upregulators of Ca V 1.2 channels could similarly nullify Rem block of I Ca,L . In heart, activation of ␤-adrenergic receptors strongly enhances I Ca,L via the Gs␣-cAMP-protein kinase (PK)A signal transduction cascade. 27, 28 In control myocytes expressing Rem 265 , exposure to 1 mol/L isoproterenol rapidly increased I Ca,L across all voltages ( Figure 4A and 4B) . On average, 1 mol/L isoproterenol resulted in a nearly 3-fold increase in I Ca,L , similar to the magnitude of response obtained with 1 mol/L BAY K 8644 ( Figure 4E ). Surprisingly, in sharp contrast to our observations with BAY K 8644, isoproterenol did not increase I Ca,L at any voltage in cells expressing CFP-Rem ( Figure 4C through 4E) . The same qualitative result was obtained when 1 mol/L forskolin was used to activate the PKA pathway downstream of the ␤-adrenergic receptor, at the level of adenylyl cyclase ( Figure  4E ). One possible explanation for the ineffectiveness of the PKA pathway to upregulate Rem-inhibited Ca V 1.2 channels is that Rem may have an unrecognized ability to eliminate or disrupt this signal transduction cascade in cells. We explored this possibility by evaluating ␤-adrenergic regulation of I KS (slow component of the delayed rectifier potassium current) in control and Rem-expressing myocytes. Under both conditions, 1 mol/L isoproterenol increased I KS to the same extent ( Figure 4F and 4G) , demonstrating the ␤-adrenergic receptor signaling pathway remained intact in myocytes expressing Rem. Recently, it has been reported that Rad similarly inhibits ␤-adrenergic regulation of I Ca,L in heart, 29 suggesting this may be a general property of all RGK GTPases. Ca V 1.2 channels prominently control the cardiac action potential duration (APD) and also provide the trigger Ca 2ϩ for Ca 2ϩ -induced Ca 2ϩ release that underlies cardiac excitation-contraction coupling. Therefore, it might be expected that the divergent effects of BAY K 8644 and forskolin on Rem-inhibited Ca V 1.2 channels in heart would translate into sharply differing effects of these 2 agents on cardiac excitability and contractility. To directly investigate this, we compared the impact of BAY K 8644 and forskolin on action potentials and Ca 2ϩ transients in myocytes expressing Rem 265 and Rem, respectively ( Figure 5 ). Cells expressing Rem dis-played a significantly shortened basal APD compared to control cells expressing Rem 265 (APD 50 ϭ139.3Ϯ17.3 ms, nϭ6 for Rem-expressing myocytes versus APD 50 ϭ241.9Ϯ35.6 ms, nϭ5 for Rem265 myocytes, PϽ0.05, 2-tailed unpaired t test). In myocytes expressing Rem 265 , both BAY K 8644 and forskolin markedly increased the APD by 3-fold ( Figure 5A and 5C). By contrast, in myocytes expressing Rem, the APD response to forskolin was essentially abolished whereas the response to BAY K 8644 remained intact ( Figure 5B and 5C) . Similarly, both BAY K 8644 and forskolin significantly increased the amplitude of evoked Ca 2ϩ transients in cells expressing mCherry-tagged Rem 265 ( Figure 5D ; Online Figure V) , whereas in cells expressing Rem, the response to forskolin was selectively and significantly muted ( Figure 5E ; Online Figure V) . These results mirror the differential impact of BAY K 8644 and forskolin on I Ca,L in Rem 265 -and Rem-expressing myocytes (Figures 3 and 4) .
Overall, these results demonstrate the novel finding that Rem inhibited Ca V 1.2 channels can be selectively pharmacologically rescued. Furthermore, taken together, the data provide the new insight that Rem-modified Ca V 1.2 channels in the sarcolemma are arrested in a low-P o state, rather than being completely electrically silent.
Role of GTP Binding and Membrane Localization in Rem Inhibition of Cardiac I Ca,L
We next examined the role played by GTP binding and the Rem C terminus in Rem-mediated inhibition of I Ca,L and the loss of sympathetic regulation. To examine the role of GTP binding, we introduced a T94N point mutation into the Rem NBD that is analogous to a mutation which locks Ras in a GDP-bound state. 30 1 mol/L forskolin ( Figure 6C through 6F) . These results differ from data obtained in HEK 293 cells, where Rem[T94N] effectively ablates I Ca,L . Our data also differ somewhat from a report that the analogous Rad[S105N] exerts a dominant negative effect when expressed in guinea pig and murine cardiac myocytes, resulting in increased I Ca,L . 16 By contrast, we did not observe a dominant negative function of CFP-Rem[T94N], which in this context simply behaves as if it is functionally inert with respect to Ca V 1.2 channel modulation.
Previous work has identified the distal C terminus as a locus critical to the Ca V channel blocking function of RGK GTPases. 18, 21, 22 Consistent with observations in other cells, deleting the distal Rem C terminus eliminates the capacity to block I Ca,L in heart (Figure 1 ). Previous studies have correlated this functional output of the distal C terminus with its role in autonomously targeting Rem to the plasma membrane. We investigated whether the essential role of the distal Rem C terminus could be substituted by the analogous domain from H-Ras ( Figure 7A) , which in most cell types functions as a robust membrane targeting module. Unexpectedly, in heart cells, CFP-Rem 265 -H was not targeted to the sarcolemma ( Figure 7B ), in sharp contrast to its membrane localization in other cell types (Online Figure VI) . Nevertheless, CFP-Rem 265 -H depressed cardiac I Ca,L and Ca V 1.2 channel Q max to the same extent as wild-type Rem (Figure 7B  through 7D) . Moreover, the remnant current was robustly upregulated by BAY K 8644 ( Figure 7E ) but almost completely insensitive to PKA activation ( Figure 7F ). Consistent with these findings, the APD in cells expressing CFP-Rem 265 -H was largely unaffected by forskolin, but significantly prolonged by BAY K 8644 ( Figure 7G ). Overall, these data provide the surprising insight that in heart cells membrane targeting of the Rem NBD is neither sufficient ( Figure  6 ) nor necessary (Figure 7) to reconstitute I Ca,L inhibition. This finding is opposite to conclusions based on studies from recombinant channels reconstituted in heterologous expression systems.
Discussion
In this work, we have examined the properties of Reminhibited Ca V 1.2 channels in adult heart cells. Our findings differ from prevailing views of the mechanisms underlying RGK GTPase-mediated decrease in cardiac I Ca,L and suggest new (patho)physiological ramifications for this potent form of Ca V 1.2 channel modulation. The results also suggest that RGK GTPases may potentially be exploited as novel tools to probe outstanding biophysical questions related to sympathetic modulation of Ca V 1.2 channels. We discuss these aspects of our work in relation to previous studies.
Mechanisms and Structural Determinants of the RGK GTPase/Ca V Channel Crosstalk in Heart
We found that overexpressing Rem in heart cells markedly decreased I Ca,L , similar to previous findings with Gem and Rad. 16 What is the mechanistic basis of this effect in heart? One prevailing hypothesis is that RGK GTPases inhibit I Ca,L in heart cells by interfering with the trafficking of poreforming ␣ 1C subunits to the sarcolemma, possibly by buffering endogenous Ca V ␤ subunits, thereby reducing the surface density of Ca V 1.2 channels. 16, 17 In this scenario, the residual currents remaining in the presence of RGK GTPase expression represent the small fraction of wild-type (unbound) channels that make it to the cell surface ( Figure 8A; model 1) . Our results offer several lines of proof that argue against model 1 as a viable mechanism for Rem-mediated block of I Ca,L in heart. First, contrary to the prediction of this model, we find no evidence that the surface density of Ca V 1.2 channels in heart cells is substantially diminished in the presence of Rem. The second line of evidence relates to the observed responses of Rem-inhibited Ca V 1.2 channels to BAY K 8644 and PKA activation. Model 1 predicts that the residual currents recorded in the presence of Rem would have the same magnitude of response to BAY K 8644 and PKA activation as channels from control cells (ie, a similar fold increase in I Ca,L ). Instead, we observed that Rem-inhibited channels were supramodulated by BAY K 8644 and insensi- tive to PKA activation compared to control channels. The results similarly argue against a model in which Remmodulated channels remain on the surface but are completely electrically silent ( Figure 8A; model 2) , because, in this scenario, the remnant current would still be provided by unmodified wild-type channels. Rather, the findings are consistent with the residual currents observed in Remexpressing myocytes arising from Rem-bound low-P o channels on the cell surface ( Figure 8A; model 3) . In this scenario, the enhanced fold increase in current amplitude in response to BAY K 8644 observed in Rem-modified channels is explained by the larger dynamic range available resulting from their lower basal P o ( Figure 8B ). It is not clear from our data precisely how Rem arrests Ca V 1.2 channels in a low-P o mode in the sarcolemma. An attractive hypothesis is that this is related to the decrease in Q max which, in the absence of a decrease in the physical number of surface channels, suggests a Rem-induced partial immobilization of voltage sensors. Deciphering precisely how Rem reduces channel P o and Q max remains an important challenge for the future.
Based on the assumption that Rem[T94N] is deficient in binding GTP, our results indicate that GTP binding to the NBD is necessary for Rem inhibition of Ca V 1.2 channels in heart. By contrast, several studies in other cell types have shown that GTP binding is dispensable for RGK block of Ca V 1 and 2 channels. 18, 22 This discrepancy appears to reflect a genuine difference among cell types because it has also been shown that GTP-binding-deficient Rad does not inhibit Ca V 1.2 channels in heart. 16 Another sharp distinction from previous studies concerns the role of membrane targeting in I Ca inhibition. Studies on recombinant channels reconstituted in heterologous systems, or endogenous Ca V 2.2 channels in sympathetic cervical ganglion neurons, have indicated that membrane targeting is necessary and/or sufficient for RGK GTPases to inhibit I Ca . 18, 21, 22 By contrast, we find that in heart cells membrane targeting of the Rem NBD is neither necessary nor sufficient for blocking I Ca,L . Overall, these distinctions emphasize the idea that RGK proteins use diverse mechanisms and determinants to inhibit I Ca and that different cell types may use unique subsets of the available toolkit to achieve Ca V channel block.
Surprisingly, Rem 265 -H was not targeted to the sarcolemma in heart cells. In other cell types, the H-Ras C terminus is posttranslationally processed in a sequence of enzymecatalyzed steps that convert it into an effective membranetargeting module 31 : farnesylation of the C-terminal CAAX prenylation motif at the cysteine residue followed by proteolysis of the AAX sequence; carboxymethylation of the farnesylated cysteine; and, finally, palmitoylation of the 2 cysteine residues upstream of the farnesylated cysteine (Fig- ure 7A). The lack of membrane-targeting of Rem 265 -H suggests that 1 or more catalytic components of this pathway may be lacking in adult guinea pig heart cells.
(Patho)Physiological Implications of the RGK GTPase/Ca V Channel Crosstalk in Heart
RGK proteins are expressed in hearts from different species: mRNA for Rem has been found in rat and mouse cardiomyocytes 8 ; Rad has been detected in mouse heart 17 ; and Gem expression has been characterized at the mRNA and protein levels in human and guinea pig heart, 14, 16 respectively. The powerful impact of RGK proteins on Ca V channels suggest that under physiological conditions these proteins may play an integral role in maintaining Ca 2ϩ homeostasis in cardiac myocytes. In heart, Ca 2ϩ influx through Ca V 1.2 channels is a multipurpose signal that controls various critical functions including: acting as the trigger for Ca 2ϩ -induced Ca 2ϩ release that underlies cardiac excitation-contraction coupling; adjusting the cardiac action potential duration; and regulating gene expression. 1,2 By virtue of their crosstalk with Ca V 1.2 channels in heart, RGK GTPases could play a critical role in keeping these vital functions within physiological norms. One facet of RGK GTPases that could be useful in fulfilling such a homeostatic function relates to dynamic regulation of their expression, which in some systems, has characteristics reminiscent of immediate early gene expression behavior. 10 Although potential dynamism in RGK GTPase expression in heart has not been rigorously explored, there is 1 report that conditions mimicking inflammation acutely downregulate Rem mRNA in heart. 8 Future experiments aimed at investigating how and whether the expression patterns of specific RGK proteins change under different conditions in heart will be important in defining their individual roles in maintaining cardiac Ca 2ϩ homeostasis.
Beyond the putative physiological function of RGK proteins in heart, an intriguing concept is the potential role they may play in cardiac diseases including heart failure, cardiac arrhythmias, and hypertrophy. In human heart failure, there is an Ϸ3-fold elevation in Gem GTPase mRNA. 14 Our studies suggest that such increases in RGK GTPase expression could significantly impair cardiac function because of these proteins diminishing the P o of some sarcolemmal Ca V 1.2 channels. If severe enough, such functional elimination of Ca V 1.2 channels could contribute to the phenomenon of dyssynchronous Ca 2ϩ sparks observed in failing hearts. 32, 33 Further exploration of potential linkages between RGK proteins and cardiac diseases will be an important focus of future studies. Ultimately, should harmful effects of RGK GTPases in heart be confirmed, our results suggest that functional deficits may be overcome with the use of Ca 2ϩ channel agonists but not by activating the sympathetic ␤-adrenergic pathway.
Potential Use of Rem As a Tool to Explore Biophysical Mechanisms of Ca V 1.2 Channel Modulation
A fortuitous outcome from these studies concerns the potential to exploit Rem as a tool to probe outstanding questions concerning the mechanisms underlying Ca V 1.2 channel modulation by Ca 2ϩ channel agonists and sympathetic activation. Previous single-channel studies have characterized distinct gating modes of cardiac Ca V 1.2 channels, 34, 35 including: mode 0a, which is characterized by brief infrequent openings; mode 1, which features frequent millisecond openings; and mode 2, wherein the channels display long openings with brief Overexpressing Rem or other RGK GTPases dramatically, but not completely, decrease I Ca,L . There are 3 candidate mechanisms for this effect: model 1, Rem reduces surface density of channels by disrupting trafficking; model 2, Rem renders a subpopulation of channels on the sarcolemma electrically silent; and model 3, Rem arrests virtually all surface channels in a low-P o gating mode. In models 1 and 2, the remnant current seen with Rem overexpression in myocytes represents a small fraction of unmodified wild-type channels. The pattern of responses of Remmodified channels to BAY K 8644 and PKA activation indicate that the remnant current does not emanate from wild-type channels, thus discounting models 1 and 2. Our results are consistent model 3 being the dominant mechanism of Rem inhibition of I Ca,L in heart. B, Conceptualization of impact of Rem, BAY K 8644, and PKA activation on modal gating activity of Ca V 1.2 channels in heart. Figure 8B ). In control channels, both BAY K 8644 and PKA increase the propensity for mode 2 openings from the dominant mode 1 gating mode ( Figure 8B ). 34, 35 Whether these 2 modulators use common transduction events to achieve Ca V 1.2 channel enhancement is unknown. Although we have not directly measured single-channel events here, the whole-cell data indicate Rem arrests channels in a low-P o mode. We conceptualize this low-P o mode as being akin to the described previously mode 0a. The ability of Rem to selectively prevent PKA-mediated upregulation, while preserving BAY K 8644 modulation ( Figure 8B ), may provide a discriminating tool to probe the structural determinants leading to the 2 forms of Ca V 1.2 channel modulation.
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Regarding PKA modulation of Ca V 1.2 channels, fundamental mechanistic questions remain unresolved despite intense study by many groups over almost 2 decades. 25,36 -39 For example, the precise phosphorylation site/s responsible for channel upregulation remains unclear, and how this posttranslational modification is transduced into a functional effect on channel gating is unknown. The ability of Rem to block PKA-mediated enhancement of I Ca,L at the level of Ca V 1.2 channels could provide a unique tool to gain new mechanistic insights into this physiologically important form of channel regulation. Potentially, Rem could nullify PKA modulation of I Ca,L either by preventing phosphorylation of the functionally relevant residues or by directly opposing the conformational change involved in the transduction event. Future work focusing on these questions will likely shed new insights into the mechanisms underlying PKA modulation of cardiac Ca V 1.2 channels.
